The Epidemiology of Multiple Myeloma
References (0)
Cited by (141)
Myeloma and Leukemia
2022, Oncologic Imaging: A Multidisciplinary ApproachMultiple Myeloma: Role of Imaging in Diagnosis, Staging, and Treatment Response Assessment
2021, Seminars in Ultrasound, CT and MRIThe CXCL12-3'A allele plays a favourable role in patients with multiple myeloma
2013, CytokineCitation Excerpt :Multiple myeloma (MM) is a plasma cell malignancy derived from an early precursor of the B-cell lineage characterized by bone marrow infiltration, lytic bone lesions and the presence of a monoclonal protein in serum and/or urine. MM account for 1% of all malignancies in Whites and 2% in US Blacks [1]. MM is rare in patients younger than 30 and its incidence increases in the elderly.
Salvage Second Hematopoietic Cell Transplantation in Myeloma
2013, Biology of Blood and Marrow TransplantationCitation Excerpt :We hypothesize that the improved OS seen in patients who underwent transplantation after 2004 is due to the use of novel agents in treatment of relapse/progression after AHCT2. MM is as twice as common among African Americans than white Americans [28]. In the US population, about 13% of individuals identify themselves in census rolls as African American/black [29].
Myeloma and Leukemia Monoclonal gammopathy of unknown significance
2012, Oncologic Imaging: A Multidisciplinary Approach Expert Consult